Predictive models in palliative care

Cancer

Volumn 115, Issue SUPPL 13, 2009, Pages 3128-3134

  Ripamonti, Carla Ida ^a   Farina, Gabriella ^b   Garassino, Marina Chiara ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

Palliative care; Prediction; Prognostic factors; Prostate cancer

Indexed keywords

C REACTIVE PROTEIN; LACTATE DEHYDROGENASE; SERUM ALBUMIN;

ADVANCED CANCER; ALBUMIN BLOOD LEVEL; ANOREXIA; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER SURVIVAL; CONFERENCE PAPER; DELIRIUM; DYSPHAGIA; DYSPNEA; HUMAN; LEUKOCYTOSIS; LIFE EXPECTANCY; LYMPHOCYTOPENIA; PALLIATIVE THERAPY; PERFORMANCE; PREDICTIVE VALIDITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; SCORING SYSTEM; SOLID TUMOR;

FORECASTING; HUMANS; MALE; MODELS, STATISTICAL; NEOPLASMS; PALLIATIVE CARE; PROGNOSIS; PROSTATIC NEOPLASMS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 67649966543     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24351     Document Type: Conference Paper

References (66)

1. Maltoni M, Caraceni A, Brunelli C, et al. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations. A study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol. 2005;23:6240-6248.
2. Parkes CM. Home or hospital? Terminal care as seen by surviving spouses. J R Coll Gen Pract. 1978;28:19-30.
3. Saunders CM. Appropriate treatment, appropriate death. In: Saunders C, ed. The Management of Terminal Disease. London, UK: Arnold; 1978:1-9.
4. Twycross RG, Litcher I. The terminal phase. In: Doyle D, Hanks G, MacDonald N, eds. Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press; 1993:651.
5. Kinzbrunner BM. Ethical dilemmas in hospice and palliative care. Support Care Cancer. 1995;3:28-36.
6. Regional Palliative Care Program. Annual Report for the Regional Palliative Care Program. Edmonton, Alberta, Canada: Regional Palliative Care Program; 1997.
7. National Hospice Organization (NHO) Newsline. 1992 stats show continued growth in programs and patients. NHO Newsline. 1993;3:1-2.
8. Steinhauser KF, Christakis NA, Clipp EC, McNeilly M, McIntyre L, Tulsky JA. Factors considered important at the end of life by patients, family, physicians and other care providers. JAMA. 2000;284:2476-2482.
9. Degner LF, Kristjanson LJ, Bowman D, et al. Information needs and decisional preferences in women with breast cancer. JAMA. 1997;277:1485-1492.
10. Steinhauser KF, Christakis Na, Clipp EC, et al. Preparing for the end of life: preferences of patients, families, physicians, and other care providers. J Pain Symptom Manage. 2001;22:727-737.
11. Vigano A, Dorgan M, Buckingham J, Bruera E, Suarez-Almazor ME. Survival prediction in terminal cancer patients: a systematic review of the medical literature. Palliat Med. 2000;14:363-374.
12. Vigano A, Bruera E, Jhangri GS, Newman SC, Fields AL, Suarez-Almazor ME. Clinical survival predictors in patients with advanced cancer. Arch Intern Med. 2000;160:861-868.
13. Cook RJ, Coleman R, Brown J, et al. Markers of bone metabolism and survival in men with hormone-refractory metastatic prostate cancer. Clin Cancer Res. 2006;12/11:3361-3367.
14. Maltoni M, Pirovano M, Nanni O, et al. Biological indexes predictive of survival in 519 Italian terminally-ill cancer patients. J Pain Symptom Manage. 1997;13:1-9.
15. Glare P, Virik K, Jones M, et al. A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ. 2003;327:195-200.
16. Glare P, Virik K. Independent prospective validation of the PaP score in terminally ill patients referred to a hospital-based palliative medicine consultation service. J Pain Symptom Manage. 2001;22:891-898.
17. Hauser CA, Stockler MR, Tattersall MHN. Prognostic factors in patients with recently diagnosed incurabile cancer: a systematic review. Support Care Cancer. 2006;14:999-1011.
18. Barbot AC, Mussault P, Ingrand P, Tourani JM. Assessing 2-month clinical prognosis in hospitalized patients with advanced solid tumors. J Clin Oncol. 2008;26:2538-2543.
19. Morita T, Tsunoda J, Inoue S, et al. Improved accuracy of physicians' survival prediction for terminally ill cancer patients using the Palliative Prognostic Index. Palliat Med. 2001;15:419-424.
20. Caraceni A, Nanni O, Maltoni M, et al. Impact of delirium on the short term prognosis of advanced cancer patients: Italian Multicenter and Study Group on Palliative Care. Cancer. 2000;89:1145-1149.
21. Maltoni M, Nanni O, Pirovano M, et al. Successful validation of the Palliative Prognostic Score in terminally ill cancer patients: Italian Multicenter and Study Group on Palliative Care. J Pain Symptom Manage. 1999;17:240-247.
22. Tamburini M, Brunelli C, Rosso S, et al. Prognostic value of quality of life scores in terminal cancer patients. J Pain Symptom Manage. 1996;1:32-41.
23. Addington-Hall JM, MacDonald LD, Anderson HR. Can the Spitzer Quality of Life Index help to reduce prognostic uncertainly in terminal care? Br J Cancer. 1990;62:695-699.
24. Cassileth BR, Lusk EJ, Miller DS, et al. Psychosocial correlates of survival in advanced malignant disease? N Engl J Med. 1985;312:1551-1555.
25. Reuben DB, Mor V, Hiris J. Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med. 1988;148:1586-1591.
26. Higginson IJ, Costantini M. Accuracy of prognosis estimates by four palliative care teams: a prospective cohort study. BMC Palliat Care. 2002;1:1.
27. Parkes CM. Accuracy of predictions of survival in later stages of cancer. BMJ. 1972;2:29-31.
28. Christakis NA, Lamont EB. Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study. BMJ. 2000;320:469-473.
29. Vigano A, Dorgan M, Buckingham J, Bruera E, Suarez-Alzamor ME. Survival prediction in terminal cancer patients: a systematic review of the medical literature. Palliat Med. 2000;14:363-374.
30. Llobera J, Esteva M, Rifa J, et al. Terminal cancer: duration and prediction of survival time. Eur J Cancer. 2000;36:2036-2043.
31. Faris M. Clinical estimation of survival and impact of other prognostic factors on terminally ill cancer patients in Oman. Support Care Cancer. 2003;11:30-34.
32. Maltoni M, Pirovano M, Scarpi E, et al. Prediction of survival of patients terminally ill with cancer. Cancer. 1995;75:2613-2622.
33. Bruera E, Miller MJ, Kuehn, et al. Estimate survival of patients admitted to a palliative care unit: a prospective study. J Pain Symptom Manage. 1992;7:82-86.
34. Evans C, McCarthy M. Prognostic uncertainty in terminal care: can the Karnofsky index help? Lancet. 1985;1:1204-1206.
35. Heyse-Moore LH, Johnson-Bell VE. Can doctors accurately predict the life-expectancy of patients with terminal cancer? Palliat Med. 1987;1:165-166.
36. Forster LE, Lynn J. Predicting life span for applicants to inpatient hospice. Arch Intern Med. 1988;148:2540-2543.
37. Oxenham D, Cornbleet MA. Accuracy of prediction of survival by different professional groups in a hospice. Palliat Med. 1998;12:117-118.
38. Pirovano M, Maltoni M, Nanni O, et al. A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. J Pain Symptom Manage. 1999;17:231-239.
39. Allard P, Dionne A, Potvin D. Factors associated with length of survival among 1081 terminally ill cancer patients. J Palliat Care. 1995;11:20-24.
40. Vigano A, Dorgan M, Buera E, et al. The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer. Cancer. 1999;86:170-176.
41. Maltoni M, Nanni O, Derni S, et al. Clinical prediction of survival is more accurate than the Karnofsky performance status in estimating life span of terminally-ill cancer patients. Eur J Cancer. 1994;30A:764-766.
42. Muers M, Shevlin P, Brown J. Prognosis in lung cancer: Physicians' opinions compared with outcome and predictive model. Thorax. 1996;51:894-902.
43. Mackillop WJ, Quirt CF. Measuring the accuracy of prognostic judgements in oncology. J Clin Epidemiol. 1997;50:21-29.
44. Tanneberger S, Malavasi I, Mariano P, et al. Planning palliative or terminal care: the dilemma of doctors' prognoses in terminally ill cancer patients. Ann Oncol. 2002;13:1320-1322.
45. Yates JW, Chalmer B, McKegner FP. Evaluation of patients with advanced cancer using the Karnofsky Performance Status. Cancer. 1980;45:2220-2224.
46. Vigano A, Donaldson N, Higginson IJ, et al. Quality of life and survival prediction in terminal cancer patients: a multicenter study. Cancer. 2004;101:1090-1098.
47. Forster LE, Lynn J. The use of physiologic measures and demographic variables to predict longevity among inpatient hospice applicants. Am J Hosp Care. 1989;6:31-34.
48. Morita T, Tsunoda J, Inoue S, et al. Survival prediction of terminally ill cancer patients by clinical symptoms: development of a simple indicator. Jpn J Clin Oncol. 1999;29:156-159.
49. Rodrigus P, de Brouwer P, Raaymakers E. Brain metastases and non-small cell lung cancer: prognostic factors and correlation with survival after irradiation. Lung Cancer. 2001;32:129-136.
50. Teunissen SC, de Graeff A, de Haes HC, Voest EE. Prognostic significance of symptoms of hospitalized advanced cancer patients. Eur J Cancer. 2006;42:2510-2516.
51. Muers MF. Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organization Thoraxic Group. Thorax. 1993;48:339-343.
52. Higginson I, McCarthy M. Measuring symptoms in terminal cancer: are pain and dyspnoea controlled? J R Soc Med. 1989;82:264-267.
53. Reuben DB, Mor V. Dyspnea in terminally ill cancer patients. Chest. 1986;89:234-236.
54. Grond S, Zech D, Diefenbach C, et al. Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic. J Pain Symptom Manage. 1994;9:372-382.
55. Ventafridda V, Ripamonti C, De Conno F, Tamburini M, Cassileth BR. Symptom prevalence and control during cancer patient's last days of life. J Palliat Care. 1990;6:7-11.
56. Krech RL, Walsh D. Symptoms in pancreatic cancer. J Pain Symptom Manage. 1991;6:360-367.
57. Heyse-Moore LH, Ross V, Mullee MA. How much of a problem is dyspnea in advanced cancer? Palliat Med. 1991;5:20-26.
58. Hardy JR, Turner R, Saunders M, A'Hern R. Predictor of survival in a hospital-based continuing care unit. Eur J Cancer. 1994;30A:284-288.
59. Escalante CP, Martin CG, Elting LS, et al. Dyspnea in cancer patients. Etiology, resource utilization, and survival. Implications in a managed care world. Cancer. 1996;78:1314-1319.
60. Bruera E. Clinical management of cachexia and anorexia in patients with advanced cancer. Oncology. 1992;49(suppl 2):35-42.
61. Barbot AC, Mussault P, Ingrand P, Tourani JM. Assessing 2-month clinical prognosis in hospitalized patients with advanced solid tumors. J Clin Oncol. 2008;26:2538-2543.
62. Stone PC, Lund S. Predicting prognosis in patients with advanced cancer. Ann Oncol. 2007;18:971-976.
63. Morita T, Tsunoda J, Inoue S, Chihara S. The Palliative Prognostic Index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer. 1999;7:128-133.
64. Yun YH, Heo DS, Heo BY, Yoo TW, Bae JM, Ahn SH. Development of terminal cancer prognostic score as an index in terminally ill cancer patients. Oncol Rep. 2001;8:795-800.
65. Chuang RB, Hu WY, Chiu TY, Chen CY. Prediction of survival in terminal patients in Taiwan: constructing a prognostic scale. J Pain Symptom Manage. 2004;28:115-122.
66. Glare PA, Eychmueller S, McMahon P. Diagnostic accuracy of the palliative prognostic score in hospitalized patients with advanced cancer. J Clin Oncol. 2004;22:4823-4828.